Treatment of chronic hyponatremia: now we know how, but do we know when or if?
Publication
, Journal Article
Greenberg, A; Lehrich, RW
Published in: J Am Soc Nephrol
April 2010
Duke Scholars
Published In
J Am Soc Nephrol
DOI
EISSN
1533-3450
Publication Date
April 2010
Volume
21
Issue
4
Start / End Page
552 / 555
Location
United States
Related Subject Headings
- Urology & Nephrology
- Tolvaptan
- Hyponatremia
- Humans
- Chronic Disease
- Benzazepines
- Antidiuretic Hormone Receptor Antagonists
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Greenberg, A., & Lehrich, R. W. (2010). Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol, 21(4), 552–555. https://doi.org/10.1681/ASN.2010020157
Greenberg, Arthur, and Ruediger W. Lehrich. “Treatment of chronic hyponatremia: now we know how, but do we know when or if?” J Am Soc Nephrol 21, no. 4 (April 2010): 552–55. https://doi.org/10.1681/ASN.2010020157.
Greenberg A, Lehrich RW. Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol. 2010 Apr;21(4):552–5.
Greenberg, Arthur, and Ruediger W. Lehrich. “Treatment of chronic hyponatremia: now we know how, but do we know when or if?” J Am Soc Nephrol, vol. 21, no. 4, Apr. 2010, pp. 552–55. Pubmed, doi:10.1681/ASN.2010020157.
Greenberg A, Lehrich RW. Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol. 2010 Apr;21(4):552–555.
Published In
J Am Soc Nephrol
DOI
EISSN
1533-3450
Publication Date
April 2010
Volume
21
Issue
4
Start / End Page
552 / 555
Location
United States
Related Subject Headings
- Urology & Nephrology
- Tolvaptan
- Hyponatremia
- Humans
- Chronic Disease
- Benzazepines
- Antidiuretic Hormone Receptor Antagonists
- 3202 Clinical sciences
- 1103 Clinical Sciences